CD8A and colorectal cancer: Yu et al. have indicated that ICA produced by Lactobacillus helveticus enhances CD8+ T cell functions by inhibiting the differentiation of CD4+ Treg cells, improving anti‐PD1 therapeutic efficacy in colorectal cancer [43].